The Impact of Rescheduling Cannabis on Federal Research Changes
Rescheduling cannabis research federal changes remove significant barriers to clinical trials. This shift enables physicians to rely on evidence-based data for prescribing decisions. It marks a critical move toward advancing patient care and expanding…
In the Mix: 8 More Articles — March 11, 2026
This article collection focuses on cannabinoid-based symptom management and its evolving clinical relevance. Recent developments highlight regulatory challenges and market dynamics. Clinicians must navigate these complexities carefully.
Challenges in Cannabis Impairment Detection for Driving Safety
Cannabis impairment detection remains a critical challenge in driving safety enforcement. This case highlights the risks of cannabis intoxication on motor function and judgment. Clinicians should counsel patients on cannabis use and driving safety.
How Rescheduling Will Impact Cannabis Intellectual Property Valuations
Cannabis intellectual property valuation will significantly shift following federal rescheduling, reshaping medical cannabis operators' asset pricing. This change primarily impacts pharmaceutical-grade cannabis products developed under strict research…
Limited Doctors and Long Drives Challenge Medical Cannabis Patients
Medical cannabis physician scarcity is a major barrier for patients seeking care in Alabama. Limited provider availability forces patients to travel long distances, delaying treatment. This scarcity highlights the need for more clinicians trained in…
How Federal Rescheduling Could Influence Tennessee Medical Cannabis Legalization
Tennessee medical cannabis legalization prospects are evolving with federal rescheduling discussions. This shift could allow clinicians to recommend cannabis legally, expanding treatment options. Tennessee healthcare providers should stay informed about…
Texas Set to Ban Smokable Hemp THC Flower by March 31
The Texas hemp smokable THC ban will take effect on March 31, changing how hemp-derived THC flower is regulated. This policy impacts clinicians' ability to recommend smokable hemp products. Patients using these products should be counseled on…
The Science Behind Cannabis Munchies and What People Actually Eat – The Fresh Toast
Cannabis appetite stimulation neurobiology reveals how THC activates hunger pathways in the brain. This effect, known as the munchies, has clinical relevance for therapeutic use. Understanding these mechanisms helps clinicians counsel patients on…
Cannabis Clinical Relevance and Treatment Pathways 2026
This alert highlights cannabis clinical treatment pathways emerging in 2026. Clinicians need evidence-based guidance for counseling patients, especially veterans. Regulated pathways promise safer, standardized cannabis use in clinical practice.
Federal Law Bars Workers Compensation Coverage for Medical Marijuana Use
Federal workers compensation cannabis coverage is prohibited under federal law, despite state medical marijuana programs. Injured workers may face out-of-pocket costs for cannabis treatments. Clinicians should counsel patients on insurance limitations…
